Long‐lasting enhancement of corticostriatal neurotransmission by taurine

Taurine occurs at high concentrations in the forebrain and its distribution varies with (patho)physiological conditions; however, its role in neural function is poorly understood. We have now characterized its effects on corticostriatal synaptic transmission. Bath application of taurine (10 mm) to slices obtained from mice and rats exerted a biphasic action on corticostriatal field potentials. The fast and reversible inhibition by taurine was accompanied by a depolarization and conductance increase in medium spiny neurons and was sensitive to γ‐aminobutyric acid (GABA)A and glycine receptor (GlyR) antagonists. A long‐lasting enhancement (LLETAU) of field potentials was recorded after taurine withdrawal. The LLETAU was not prevented by N‐methyl‐d‐aspartate (NMDA)‐ or by GABAA receptor‐antagonists, but was sensitive to the GlyR‐antagonist strychnine and blocked by the competitive taurine uptake inhibitor guanidinoethylsulphonate (GES, 1 mm). GES at 10 mm evoked an enhancement of field potentials similar to LLETAU. LLETAU depended on protein kinase C activation as it was blocked by chelerythrine, but was unaffected by trifluoperazine, and thus independent of calmodulin. LLETAU was significantly smaller in juvenile than in mature rodents. Activation of GlyRs and the specific taurine transporter by taurine evoke a long‐lasting enhancement of corticostriatal transmission.

[1]  M. Francaux,et al.  Effects of guandinoethane sulfonate on contraction of skeletal muscle. , 2000, Advances in experimental medicine and biology.

[2]  G Bernardi,et al.  Synaptic transmission in the striatum: from plasticity to neurodegeneration , 2000, Progress in Neurobiology.

[3]  A. Quesada,et al.  Effects of the taurine transport antagonist, guanidinoethane sulfonate, and β‐alanine on the morphology of rat retina , 1983, Journal of neuroscience research.

[4]  A. D. Smith,et al.  Uptake of [3H]taurine into medium-size neurons and into identified striatonigral neurons in the rat neostriatum , 1983, Brain Research.

[5]  A. Hamberger,et al.  Regulation of glutamate biosynthesis and release in vitro by low levels of ammonium ions , 1982, Brain Research.

[6]  M. Palkovits,et al.  Taurine Levels in Discrete Brain Nuclei of Rats , 1986, Journal of neurochemistry.

[7]  R. Huxtable.  Guanidinoethane sulfonate and the disposition of dietary taurine in the rat. , 1982, The Journal of nutrition.

[8]  J. Lombardini.  HIGH AFFINITY UPTAKE SYSTEMS FOR TAURINE IN TISSUE SLICES AND SYNAPTOSOMAL FRACTIONS PREPARED FROM VARIOUS REGIONS OF THE RAT CENTRAL NERVOUS SYSTEM. CORRECTION OF TRANSPORT DATA BY DIFFERENT EXPERIMENTAL PROCEDURES , 1977, Journal of neurochemistry.

[9]  G. Rebel,et al.  Activation of protein kinase C down-regulates glial but not neuronal taurine uptake , 1996, Neuroscience Letters.

[10]  A. Kriegstein,et al.  Nonsynaptic Glycine Receptor Activation during Early Neocortical Development , 1998, Neuron.

[11]  N. Hussy,et al.  Agonist action of taurine on glycine receptors in rat supraoptic magnocellular neurones: possible role in osmoregulation , 1997, The Journal of physiology.

[12]  B. Platt,et al.  Glycine induces a novel form of long‐term potentiation in the superficial layers of the superior colliculus , 1998, British journal of pharmacology.

[13]  R. Cutler,et al.  REGIONAL CHANGES IN AMINO ACID CONTENT IN DEVELOPING RAT BRAIN 1 , 1974, Journal of neurochemistry.

[14]  Robert C. Malenka,et al.  Potentiation of synaptic transmission in the hippocampus by phorbol esters , 1986, Nature.

[15]  J. Mellor,et al.  The taurine uptake inhibitor guanidinoethyl sulphonate is an agonist at γ-aminobutyric acidA receptors in cultured murine cerebellar granule cells , 2000, Neuroscience Letters.

[16]  N. Nelson,et al.  Cloning and expression of a cDNA encoding the transporter of taurine and beta-alanine in mouse brain. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[17]  S. Oja,et al.  Taurine and neural cell damage , 2000, Amino Acids.

[18]  M. Galarreta,et al.  Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus , 1996, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[19]  M. Galarreta,et al.  Taurine-induced synaptic potentiation: role of calcium and interaction with LTP , 2000, Neuropharmacology.

[20]  J. Olson,et al.  Hyperosmotic exposure alters total taurine quantity and cellular transport in rat astrocyte cultures. , 1996, Biochimica et biophysica acta.

[21]  I. Módy,et al.  Shunting of excitatory input to dentate gyrus granule cells by a depolarizing GABAA receptor-mediated postsynaptic conductance. , 1992, Journal of neurophysiology.

[22]  R. Böckelmann,et al.  Potassium-Stimulated Taurine Release and Nitric Oxide Synthase Activity During Quinolinic Acid Lesion of the Rat Striatum , 1998, Neurochemical Research.

[23]  M. Frotscher,et al.  Identification of projecting neurons in rat neostriatal slices , 1984, Brain Research.

[24]  L. Hösli,et al.  The depression of brain stem neurones by taurine and its interaction with strychnine and bicuculline. , 1973, Brain research.

[25]  H. Haas,et al.  Expression and function of glycine receptors in striatal cholinergic interneurons from rat and mouse , 2001, Neuroscience.

[26]  O. Sergeeva.  Comparison of glycine- and GABA-evoked currents in two types of neurons isolated from the rat striatum , 1998, Neuroscience Letters.

[27]  H. Haas,et al.  Guanidinoethyl sulphonate is a glycine receptor antagonist in striatum , 2002, British journal of pharmacology.

[28]  R. Huxtable.  Taurine in the central nervous system and the mammalian actions of taurine , 1989, Progress in Neurobiology.

[29]  Y. Kawaguchi.  Neostriatal cell subtypes and their functional roles , 1997, Neuroscience Research.

[30]  R. Sullivan,et al.  Localization of taurine transporters, taurine, and 3H taurine accumulation in the rat retina, pituitary, and brain , 2002, Glia.

[31]  R J Huxtable,et al.  Physiological actions of taurine. , 1992, Physiological reviews.

[32]  H. Pasantes‐Morales,et al.  Effect of guanidinoethane sulfonate on taurine uptake by rat retina , 1984, Journal of neuroscience research.

[33]  E. Ambrosio,et al.  The epileptogenic action of the taurine analogue guanidinoethane sulfonate may be caused by a blockade of GABA receptors , 1990, Journal of neuroscience research.

[34]  J. Bolam,et al.  The in vivo release of taurine in the striatonigral pathway. , 1998, Advances in experimental medicine and biology.

[35]  Y. Izumi,et al.  LTP in CA1 of the adult rat hippocampus and voltage‐activated calcium channels , 1998, Neuroreport.

[36]  M. Baudry,et al.  High concentrations of glycine induce long-lasting changes in synaptic efficacy in rat hippocampal slices , 1993, Neuroscience Letters.

[37]  M. Zielińska,et al.  Changes in the extracellular profiles of neuroactive amino acids in the rat striatum at the asymptomatic stage of hepatic failure , 1999, Journal of neuroscience research.

[38]  S. Oja,et al.  Enhanced taurine release in cell-damaging conditions in the developing and ageing mouse hippocampus , 1997, Neuroscience.

[39]  T. Bliss,et al.  A synaptic model of memory: long-term potentiation in the hippocampus , 1993, Nature.